Fentanyl Mixed with Xylazine in Florida: The Real Dangers and What Actually Helps

Florida is facing a growing problem with dangerous drug combinations. The abuse of fentanyl mixed with xylazine has reached alarming levels. These substances, known as “tranq dope,” are causing serious harm in communities. Fentanyl is a synthetic opioid used to treat severe pain, while xylazine is a veterinary sedative. When combined, the effects can be devastating and unpredictable, increasing the risk of fatal overdoses. A rehab center in Boynton Beach can be a lifeline for those affected by this crisis.

The Growing Problem

The good news first: overdose deaths in Florida have been dropping sharply. Opioid deaths fell 42%, and fentanyl deaths fell 46% in the first half of 2025 compared to the year before, according to the Florida Medical Examiners Commission. This is real progress, driven largely by wider naloxone access and a national shift toward smoking rather than injecting fentanyl. But xylazine complicates that picture in a way fentanyl alone doesn’t.

Nationally, xylazine-involved overdose deaths rose 276% across 21 monitored jurisdictions between 2019 and 2022, according to the CDC. In Florida specifically, the state began tracking xylazine in autopsy data for the first time in 2022, finding it present in 471 deaths statewide that year. Palm Beach County alone accounted for 44 of those deaths — the third-highest count of any county in the state. That’s a sharp rise for a substance drug dealers only started mixing into the fentanyl supply in recent years, and it’s part of why the two are now so frequently found together.

Understanding Fentanyl and Xylazine

Fentanyl and xylazine come from entirely different drug classes, developed for different purposes, decades apart. That difference is exactly what makes their combination so unpredictable. One is an opioid painkiller diverted from medical use into the illegal drug supply; the other is an animal sedative that was never approved for humans at all. Understanding what each drug actually does on its own is what makes it possible to understand why combining them creates risks that neither drug produces by itself.

Fentanyl

Fentanyl is a synthetic opioid estimated to be 50 to 100 times stronger than morphine, and far more dangerous than other opioids like heroin, due to its extreme potency and the razor-thin margin between a safe dose and a fatal one — sometimes as little as a few micrograms. It was originally developed for medical use, prescribed for severe pain in settings like cancer treatment or major surgery. But in illegal drug markets, dealers mix it into other substances to increase potency and profits, often without the buyer’s knowledge. That practice is a major driver of the rising need for fentanyl rehab across Florida and the country.

Xylazine

Xylazine was developed in the 1960s as a veterinary sedative for large animals like horses and cattle. It was actually tested for human use decades ago, but those trials were stopped after it caused severe, dangerous drops in blood pressure. So it has never been approved for humans, only animals. Pharmacologically, it belongs to a class of drugs called alpha-2 adrenergic agonists, which produce sedation, muscle relaxation, and pain relief by suppressing activity in the central nervous system.

On the street, xylazine earned the nickname “tranq” for the deep, prolonged sedation it causes. Other times it is described as leaving users in a stiff, unresponsive, “zombie-like” state that can last for hours, far longer than fentanyl’s effects alone. It first began appearing in the drug supply in Puerto Rico and later in Philadelphia before spreading to illicit markets nationwide, including Florida. Dealers add it to fentanyl because it intensifies and extends the high at a low cost. But combined with fentanyl’s own respiratory-suppressing effects, it can create amplified overdose risk that’s much harder to reverse than a fentanyl overdose alone.

Why Xylazine Causes Severe Skin Wounds

One of xylazine’s most distinctive and dangerous effects has nothing to do with overdose directly: it causes severe, often necrotic skin wounds, sometimes requiring amputation. This isn’t random. As mentioned, xylazine is an alpha-2 adrenergic agonist. In other words, it triggers strong constriction of blood vessels near the skin’s surface. That constriction cuts off blood flow and oxygen to surrounding tissue, and prolonged oxygen deprivation causes the tissue to die (necrosis), forming open wounds that heal poorly and are easily infected.

What makes this especially dangerous is that these wounds can appear anywhere on the body, not just at injection sites — a South Florida case report documented this pattern directly, describing necrotic ulcers forming even in a patient who wasn’t injecting near the wound site. Left untreated, these wounds can progress to the point of requiring surgical amputation.

Why Naloxone Isn’t Enough

Naloxone is the standard emergency response to an opioid overdose, and it works well. It binds to the same opioid receptors fentanyl does, displacing the drug and rapidly restoring normal breathing. It’s the reason so many fentanyl overdoses are survivable when naloxone is on hand, and why wider naloxone access has been a major factor in the recent decline in overdose deaths.

But that reversal only works on the opioid part of the equation. Xylazine doesn’t touch opioid receptors at all. It acts on a completely different part of the nervous system. The same alpha-2 adrenergic receptors described earlier are responsible for the deep sedation and blood vessel constriction. Naloxone has no biochemical mechanism for interacting with that receptor system. In other words, it simply can’t reverse anything xylazine is doing.

In practice, this creates a dangerous illusion during an overdose. Naloxone can successfully reverse the fentanyl component within minutes. A bystander may see the person start breathing more normally and assume the crisis has passed. But if xylazine is also present, its sedative and respiratory-depressing effects continue completely unaffected. As a result, the person can remain unresponsive or slip back into dangerous breathing suppression even after naloxone has technically “worked.” This is exactly why the standard overdose response still matters even when naloxone doesn’t fully resolve things. Call 911 immediately, administer naloxone anyway since fentanyl is almost always present in these combinations. Also, continue rescue breathing and close monitoring until emergency responders arrive, rather than assuming the situation is resolved just because naloxone was given.

Xylazine Withdrawal: A Different, More Complicated Problem

Xylazine doesn’t just complicate overdose response — it complicates treatment itself, in a way most people don’t expect. Because xylazine isn’t an opioid, standard opioid withdrawal medications like buprenorphine and methadone don’t fully address withdrawal on their own. A 2025 clinical study found that withdrawal from xylazine, when it co-occurs with opioid withdrawal, tends to be more severe than opioid withdrawal alone, and can even interfere with starting buprenorphine treatment safely.

There’s currently no FDA-approved medication specifically for xylazine withdrawal. Managing it typically requires a combination of approaches, including medications like clonidine for anxiety and agitation, alongside close medical monitoring for cardiovascular instability, which is a meaningfully more complex undertaking than standard opioid detox alone.

Making this even more volatile: medetomidine. This sedative, similar to xylazine but reportedly more potent, has begun appearing in the illicit drug supply as well. Physicians have observed that medetomidine withdrawal can be even more severe than xylazine withdrawal, undermining treatment protocols developed specifically around xylazine. The practical takeaway is that the “tranq dope” supply isn’t a fixed, known quantity. It’s actively evolving, which is exactly why professional, adaptable treatment matters more here than in most other substance use situations.

Prevention That Actually Works

Real prevention here isn’t abstract awareness campaigns but specific, practical steps that reduce risk:

• Test strips. Fentanyl test strips have long been decriminalized in Florida, and as of this year, the state legislature has also decriminalized xylazine test strips. This gives people a real way to check what they’re using before they use it.
• Never use alone. Since naloxone alone may not resolve a fentanyl-xylazine overdose, having someone present who can call 911 and perform rescue breathing is critical.
• Wound care matters immediately, not eventually. Because xylazine wounds progress quickly and heal poorly, seeking medical attention for any unusual skin changes, even ones that seem minor, can prevent the kind of severe tissue damage that leads to amputation.
• Naloxone access programs exist and are actively working. Organizations like the Florida Harm Reduction Collective distribute thousands of naloxone doses across the state every month at no cost, specifically to close the gap between when an overdose happens and when emergency help arrives.

In addition to these, support systems, such as an intensive outpatient program in Florida, provide early intervention before substance use becomes life-threatening, combining counseling, therapy, and medical care in a structured but flexible environment.

Getting Help

Recovering from fentanyl and xylazine use requires professional support. And given how much more complicated xylazine withdrawal is compared to opioid withdrawal alone, medical supervision isn’t optional here the way it might be a closer call for other substances. A partial hospitalization program in Florida offers structured, intensive treatment during the day while allowing patients to return home at night. For more complex cases, a full addiction treatment center in Florida can build a personalized recovery plan addressing both the substance use and any co-occurring conditions.

Taking Action Against Fentanyl Mixed with Xylazine

Fentanyl mixed with xylazine presents a serious, evolving threat across Florida. On one hand, overall overdose deaths are declining, but the specific risks of wound damage, naloxone resistance, and complicated withdrawal haven’t gone anywhere. All of these are getting more unpredictable as substances like medetomidine enter the supply. Understanding what makes this combination different, and taking concrete steps like using test strips and never using alone, are what actually reduce harm. If you or someone you love is affected, reaching out for help is a courageous step toward healing, and it’s never too late to take it.

FAQs

Is xylazine a controlled substance?

Not currently at the federal level, though a growing number of states have moved to schedule it given its role in the overdose crisis.

Is xylazine detected in standard drug tests?

No. Routine toxicology screens don't test for xylazine — detecting it requires additional, specific testing methods, which is part of why its true prevalence in overdose deaths may be underestimated.

Why does xylazine cause skin wounds?

Xylazine constricts blood vessels near the skin, cutting off blood flow and oxygen to tissue. Over time, this causes tissue death and open wounds that heal poorly and are prone to infection — sometimes severe enough to require amputation.

Does xylazine make a fentanyl overdose more likely to be fatal?

It's not entirely confirmed. What is clear is that xylazine's own extreme sedation can cause breathing to stop on its own, independent of fentanyl — which is dangerous regardless of whether the combination is proven to compound fatality risk specifically.

Should you give naloxone if you suspect xylazine is involved in an overdose?

Yes. Naloxone should still be given for any suspected overdose, since fentanyl is almost always present alongside xylazine. It won't reverse xylazine's effects, but it will reverse the opioid component, which is why it remains a critical first step even in a suspected tranq dope overdose.

Is xylazine withdrawal treated the same way as opioid withdrawal?

No. Standard opioid withdrawal medications like buprenorphine and methadone don't fully address xylazine withdrawal, which research shows can actually be more severe than opioid withdrawal alone.